A hyperlipidemic diet induces structural changes in cerebral blood vessels

Current Neurovascular Research

Volumn 8, Issue 2, 2011, Pages 131-144

  Constantinescu, Elena ^a   Safciuc, Florentina ^a   Sima, Anca V ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Amyloid; Cerebral vessels; Electron microscopy; Hamster; Histochemistry; Hyperlipidemia; Neurodegeneration

Indexed keywords

AMYLOID; CHOLESTEROL; DIRECT YELLOW 7; LIPOPROTEIN; PARAFFIN; THIOFLAVINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN CORTEX; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HAMSTER; HISTOCHEMISTRY; HISTOGRAM; HYPERLIPIDEMIC DIET; LIPID DIET; MALE; MENINX; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; STAINING; STRUCTURE ANALYSIS;

EID: 79955732894     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720211795495330     Document Type: Article

References (78)

1. Winblad B. A bridge between brain and aging research. Brain Aging Internat J 2001; 1: 3.
2. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002; 33: 1152-62.
3. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64: 575-611. (Pubitemid 32304447)
4. Humpel C, Marksteiner J. Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res 2005; 2: 341-47. (Pubitemid 41297371)
5. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004; 5: 347-60. (Pubitemid 38568496)
6. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22. (Pubitemid 36359297)
7. Moser KV, Stockl P, Humpel C. Cholinergic neurons degenerate when exposed to conditioned medium of primary rat brain capillary endothelial cells: Counteraction by NGF, MK-801 and inflammation. Exp Gerontol 2006; 41: 609-18. (Pubitemid 43867224)
8. Zlokovic BV, Yamada S, Holtzman D, Ghiso J, Frangione B. Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat Med 2000; 6: 718.
9. Bell RD, Zlokovic BV. Neurovascular mechanisms and blood- brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009; 118: 103-13.
10. Smith EE, Greenberg SM. Beta-amyloid, blood vessels, and brain function. Stroke 2009; 40: 2601-06.
11. Ishikawa M, Stokes KY, Zhang JH, Nanda A, Granger DN. Cerebral microvascular responses to hypercholesterolemia. Roles of NADPH oxidase and P-selectin. Circ Res 2004; 94: 239-44.
12. Wolozin B. Cholesterol and the biology of Alzheimer's disease. Neuron 2004; 41: 7-10. (Pubitemid 38068431)
13. Kunjathoor VV, Tseng AA, Medeiros LA, Khan T, Moore KJ. Beta-amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins. J Neuroinflammation 2004; 1: 23.
14. Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. Ann N Y Acad Sci 2000; 903: 335-44. (Pubitemid 30251574)
15. Ghribi O, Golovko MY, Larsen B, Schrag M, Murphy EJ. Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol enriched diets. J Neurochem 2006; 99(2): 438-49. (Pubitemid 44477201)
16. Schulz B, Liebisch G, Grandl M, et al. Beta-amyloid (A40, A42) binding to modified LDL accelerates macrophage foam cell formation. Biochim Biophys Acta 2007; 1771: 1335-44. (Pubitemid 47499234)
17. Refolo LM, Pappolla MA, Malester B, et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7: 321-31.
18. Zhang Q, Powers ET, Nieva J, et al. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 4752-7. (Pubitemid 38469149)
19. Dei R, Takeda A, Niwa H, et al. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol (Berl) 2002; 104: 113-2. (Pubitemid 36075368)
20. Hooijmans CR, Rutters F, Dederen PJ, et al. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol Dis 2007; 28: 16-29. (Pubitemid 47432903)
21. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for latelife Alzheimer disease. Ann Intern Med 2002; 137: 149-55. (Pubitemid 34827510)
22. McKhann GM, Selnes OA. Vascular cognitive change: perspective from neurology. Alzheimer's Dementia 2007; 3: S23-S29. (Pubitemid 46554907)
23. Beach TG, Wilson JR, Sue LI, et al. Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 2007; 113:13-21. (Pubitemid 44782925)
24. Honig LS, Walter KW, Mayeux R. Atherosclerosis and AD. Analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005; 64: 494-500. (Pubitemid 40189869)
25. Friedhoff LT, Cullen EI, Geoghagen NS, Buxbaum JD. Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide. Int J Neuropsychopharmacol 2001; 4: 127-30. (Pubitemid 32587379)
26. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000; 356: 1627-31.
27. Rockwood K, Kirkland S, Hogan DB. Use of lipid-lowering agents, indication bias, and the risk of dementia in community dwelling elderly people. Arch Neurol 2002; 59: 223-7. (Pubitemid 34240938)
28. Farooqui AA, Ong WY, Horrocksa LA, Chenc P, Farooqui T. Comparison of biochemical effects of statins and fish oil in brain: The battle of the titans. Brain Res Revs 2007; 56: 443-71. (Pubitemid 350166530)
29. Wood WG, Igbavboa U, Eckert GP, Johnson-Anuna LN, Müller WE. Is hypercholesterolemia a risk factor for Alzheimer's disease? Mol Neurobiol 2005; 31: 185-92. (Pubitemid 41271202)
30. Knittweis JW, McMullen WA. The effect of apoE on dementia is not through atherosclerosis: The Rotterdam Study: to the Editor. Neurology 2000; 54: 2356-8. (Pubitemid 30416303)
31. Umeda T, Mori H, Zheng H, Tomiyama T. Regulation of cholesterol efflux by amyloid b secretion. J Neurosci Res 2010; 88: 1985-94.
32. Süle Z, Mracskó E, Bereczki E, et al. Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice. Life Sci 2009; 19: 935-9.
33. Mandavilli A. The amyloid code. Of mice and men. Nature Med 2006; 12(7): 747-51.
34. Elder GA, Cho JY, English DF, et al. Elevated plasma cholesterol does not affect brain Ab in mice lacking the low-density lipoprotein receptor. J Neurochem 2007; 102: 1220-31. (Pubitemid 47174226)
35. Breslow JL. Mouse models of atherosclerosis. Science 1996; 272:685-8. (Pubitemid 26000273)
36. Nistor A; Bulla A; Filip DA; Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis, Atherosclerosis 1987; 68: 159-73.
37. Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009; 335: 191-203.
38. Sima A, Bulla A, Simionescu N. Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. J Submicrosc Cytol Pathol 1990; 22: 1-16. (Pubitemid 20110944)
39. Finn AV, Kolodgie FD, Virmani R. Correlation Between Carotid Intimal/Medial Thickness and Atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 177-81.
40. Safciuc F, Constantinescu E, Sima A. The hyperlipidemic diet induces localized amyloidoses in hamster. Proc Rom Acad Series 2010; 2: 91-8.
41. McGowan E, Eriksen J, Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trend Genetics 2006; 22: 5.
42. Epis R, Gardoni F, Marcello E, et al. Searching for new animal models of Alzheimer?s disease. Eur J Pharmacol 2010; 626: 57-63.
43. Shie FS, Jin LW, Cook DG, Leverenz JB, LeBoeuf RC. Dietinduced hypercholesterolemia enhances brain A-beta accumulation in transgenic mice. Neuroreport 2002; 13: 455-9. (Pubitemid 34293189)
44. Levin-Allerhand JA, Lominska CE, Smith JD. Increased amyloidlevels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J Nutr Health Aging 2002; 6: 315-9. (Pubitemid 36118979)
45. Ban Y, Watanabe T, Suguro T, et al. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia. J Atheroscler Thromb 2009; 16: 179-87.
46. Newaz MA, Yousefipour Z, Nawal NN. Modulation of nitric oxide synthase activity in brain, liver, and blood vessels of spontaneously hypertensive rats by ascorbic acid: protection from free radical injury. Clin Exp Hypertens 2005; 27: 497-508. (Pubitemid 41170281)
47. Scheibel AB. Alterations of the cerebral capillary bed in the senile dementia of Alzheimer. Italian J Neurol Sci 1987; 8(5): 457-63.
48. Buee L, Hof PR, Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Ann NY Acad Sci 1997;826: 7-24. (Pubitemid 27478027)
49. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Therapeutics 1996; 72(3): 193-214. (Pubitemid 26425810)
50. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64: 575-611. (Pubitemid 32304447)
51. Hashimura T, Kimura T, Miyakawa T. Morphological changes of blood vessels in the brain with Alzheimer's disease. Jpn J Psychiatry Neurol 1991; 45(3): 661-5.
52. Kimura T, Hashimura T, Miyakawa T. Observations of microvessels in the brain with Alzheimer's disease by scanning electron microscopy. Jpn J Psychiatry Neurol 1991; 45(3): 671-6.
53. Simionescu N, Simionescu M. Interactions of endogenous lipoproteins with capillary endothelium in spontaneously hyperlipoproteinemic rats. Microvasc Res 1985; 30: 314-32. (Pubitemid 16125631)
54. Simionescu N, Sima A, Dobrian A, Tîrziu D, Simionescu M. Pathobiochemical changes of the arterial wall at the inception of atherosclerosis. In: Vollmer, Roessner, Eds. Current Topics in Pathology. Springer-Verlag Berlin 1993; pp. 1-45.
55. Perlmutter LS, Chui HC. Microangiopathy, the vascular basement membrane and Alzheimer's disease. Brain Res Bull 1990; 24: 677-86. (Pubitemid 20183782)
56. Claudio L. Ultrastructural features of the blood-brain barrier in biopsy tissues from Alzheimer's disease patients. Acta neuropathol 1996; 91: 6-14.
57. Farkas E, De Jong GI, Apro E, et al. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease and experimental hypertension. What is the functional link? Ann NY Acad Sci 2000; 903: 72-82. (Pubitemid 30251542)
58. Farkas E, De Jong GI, De Vos RAI, et al. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol (Berl.) 2000; 100: 395-402. (Pubitemid 30497009)
59. Wang CX, Shuaib A. Critical role of microvasculature basal lamina in ischemic brain injury. Progr Neurobiol 2007; 83:140-48. (Pubitemid 47484045)
60. Weller RO, Boche D, Nicoll JAR. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 2009; 118: 87-102.
61. Donahue JE, Johanson CE. Apolipoprotein E, Amyloid-[beta], and Blood-Brain Barrier Permeability in Alzheimer Disease. J Neuropathol Exp Neurol 2008; 67: 261.
62. Inoue S, Kuroiwa M, Kisilevsky R. Basement membranes, microfibrils and beta-amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings. Brain Res Brain Res Rev 1999; 29(2-3): 218-31. (Pubitemid 29191340)
63. Natte R, Yamaguchi H, Maat-Schieman ML, et al. Ultrastructural evidence of early non-fibrillar Abeta42 in the capillary basement membrane of patients with hereditary cerebral hemorhage with amyloidosis, Dutch type. Acta neuropathol (Berl.) 1999; 98(6): 577-82.
64. Eisele YS, Obermüller U, Heilbronner G, et al. Peripherally Applied A beta-Containing Inoculates Induce Cerebral β- Amyloidosis. Science 2010; 330: 980-2.
65. Preston SD, Steart PV, Wilkinson A, Nicoll JAR, Weller RO. Capillary and arterial amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 2003; 29: 106-17. (Pubitemid 36408329)
66. Xu F, Vitek MP, Colton CA, et al. Human Apolipoproteine Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice. J Neurosci 2008; 28: 5312-20.
67. Reiman EM, Chen K, Liu X, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 6820-25.
68. Kadir A, Marutle A, Gonzalez D, et al. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain 2011; 134: 301-17.
69. Tomic JL, Pensalfini A, Head A, Glabe CG. Soluble Fibrillar Oligomer Levels are Elevated in Alzheimer's Disease Brain and Correlate with Cognitive Dysfunction. Neurobiol Dis 2009; 35:352-8.
70. van Helmond Z, Miners JS, Kehoe PG, Love S. Oligomeric Ab in Alzheimer's disease: relationship to Plaque and Tangle Pathology, APOE Genotype and Cerebral Amyloid Angiopathy. Brain Pathol 2010; 20: 468-80.
71. Sullivan PM, Mace BE, Estrada JC, et al. Human Apolipoprotein E4 Targeted Replacement Mice Show Increased Prevalence of Intracerebral Hemorrhage Associated with Vascular Amyloid Deposition. J Stroke Cerebrovasc Dis 2008; 17: 303-11.
72. Hirano A, Kawanami T, Llena JF. Electron microscopy of the blood-brain barrier in disease. Microsc Res Tech 1994; 27: 543-56. (Pubitemid 24111781)
73. Sakata N, Ida T, Joshita T, Ooneda G. Scanning and transmission electron microscopic study on the cerebral arterial endothelium of experimentally hypertensive rats fed an atherogenic diet. Acta Pathol Jpn 1983; 33: 1105-13. (Pubitemid 14189492)
74. Liu L, Su Y, Yang W, et al. Disruption of neuronal-glial-vascular units in the hippocampus of ovariectomized mice injected with Dgalactose. Neuroscience 2010; 169: 596-608.
75. Ong WY, Tan B, Pan N, Jenner A, Whiteman M, et al. Increased iron staining in the cerebral cortex of cholesterol fed rabbits. Mech Ageing Dev 2004; 125: 305-13. (Pubitemid 38438510)
76. Mato M, Ookawara S, Sakamoto A, et al. Involvement of specific macrophage-lineage cells surrounding arterioles in barrier and scavenger function in brain cortex. Proc Natl Acad Sci USA 1996;93: 3269-74. (Pubitemid 26125607)
77. Mato M, Ookawara S, Mashiko T, et al. Regional difference of lipid distribution in brain of apolipoprotein E deficient mice. Anat Rec 1999; 256: 165-76. (Pubitemid 29442082)
78. Nakazawaa T, Nishikawaa M, Aikawaa E, Mato M. In vitro characterization of Mato's FGP cells isolated from rat cerebrum. Neurosci Lett 2002; 317: 127-30. (Pubitemid 34033728)